Literature DB >> 7901272

Infection control in hospitals: has its quality-enhancing and cost-effective role been appreciated?

A K Chaudhuri1.   

Abstract

A review of data from surveys worldwide, including the United Kingdom and the United States, or morbidity and mortality and costs incurred as direct consequences of hospital-acquired infection is presented. These data testify to the role of hitherto somewhat undervalued Infection Control in hospitals as a key factor in the quality of medical care and also establish its contribution towards cost-effectiveness in various health care systems, including the National Health Service in the UK (NHS). It is appropriate, therefore, for Infection Control to be accorded proper appreciation and adequate funding. The achievement of these aims is likely to be helped by the recent changes in the NHS management system and supported by the requirements of Medical Audit and Hospital Accreditation Schemes.

Entities:  

Mesh:

Year:  1993        PMID: 7901272     DOI: 10.1016/0195-6701(93)90003-i

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Infection control and prevention: a review of hospital-acquired infections and the economic implications.

Authors:  Deoine Reed; Sandra A Kemmerly
Journal:  Ochsner J       Date:  2009

Review 2.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 3.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

Review 4.  Assessment effects and risk of nosocomial infection and needle sticks injuries among patents and health care worker.

Authors:  Wanich Suksatan; Saade Abdalkareem Jasim; Gunawan Widjaja; Abduladheem Turki Jalil; Supat Chupradit; Mohammad Javed Ansari; Yasser Fakri Mustafa; Hayder A Hammoodi; Mohammad Javad Mohammadi
Journal:  Toxicol Rep       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.